Cross-source evidence timeline

Glepaglutide research timeline

Follow 9 selected, directly cited source records from December 22, 2017 through September 29, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

9Selected records
6Source years
2Evidence lanes
September 29, 2026Latest source date

Source year

2026

4 records
  1. Clinical trials

    ClinicalTrials.gov record NCT07197944↗

    PeptideScanner retained ClinicalTrials.gov record NCT07197944 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was glepaglutide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03905707↗

    PeptideScanner retained ClinicalTrials.gov record NCT03905707 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was glepaglutide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT04881825↗

    PeptideScanner retained ClinicalTrials.gov record NCT04881825 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-08, and PeptideScanner's reviewed identity mapping was glepaglutide.↗

  4. Literature metadata

    Exploring the disease burden and quality of life in patients with short bowel syndrome with intestinal failure: Insights from exit interviews in the glepaglutide EASE SBS-1 phase 3 trial.↗

    PubMed lists PMID 41816796 in Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, with publication-date metadata of 2026-03-12 (day precision). PeptideScanner associated the retained record with the identity slug glepaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2025

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03690206↗

    PeptideScanner retained ClinicalTrials.gov record NCT03690206 at 2026-11-16T01:46:56.290Z. Its registry update date was 2025-07-17, and PeptideScanner's reviewed identity mapping was glepaglutide.↗

Source year

2024

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT04991311↗

    PeptideScanner retained ClinicalTrials.gov record NCT04991311 at 2026-11-16T01:46:56.290Z. Its registry update date was 2024-11-22, and PeptideScanner's reviewed identity mapping was glepaglutide.↗

Source year

2021

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT04318743↗

    PeptideScanner retained ClinicalTrials.gov record NCT04318743 at 2026-11-16T01:46:56.290Z. Its registry update date was 2021-07-14, and PeptideScanner's reviewed identity mapping was glepaglutide.↗

Source year

2020

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT04178447↗

    PeptideScanner retained ClinicalTrials.gov record NCT04178447 at 2026-11-16T01:46:56.290Z. Its registry update date was 2020-11-18, and PeptideScanner's reviewed identity mapping was glepaglutide.↗

Source year

2017

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03279302↗

    PeptideScanner retained ClinicalTrials.gov record NCT03279302 at 2026-11-16T01:46:56.290Z. Its registry update date was 2017-12-22, and PeptideScanner's reviewed identity mapping was glepaglutide.↗